Virgil Thompson is of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 16,693 shares of PCSA, which is worth approximately $19,363. The most recent transaction as insider was on Aug 05, 2022, when has been sold 1,169 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.7K
0% 3M change
0% 12M change
Total Value Held $19,363

VIRGIL THOMPSON Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 05 2022
BUY
Exercise of conversion of derivative security
-
1,169 Added 6.54%
16,693 Common Stock
Mar 31 2022
BUY
Grant, award, or other acquisition
-
4,393 Added 20.83%
16,693 Common Stock
Aug 05 2021
BUY
Grant, award, or other acquisition
-
1,169 Added 8.68%
12,300 Common Stock
VT

Virgil Thompson

Hanover, MD

Track Institutional and Insider Activities on PCSA

Follow Processa Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

News

Receive news related to Processa Pharmaceuticals, Inc.

Track Activities on PCSA